AstraZeneca AZN announced that the European Medical Agency (EMA) has authorized Vaxzevria, its COVID-19 vaccine, for use as a third/booster dose in adults in Europe. A primary two-dose vaccine regimen of Vaxzevria is already authorized for use in the EU.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,